Cubist Systematic Strategies, LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$752,179
+7.8%
74,547
+5.8%
0.00%0.0%
Q3 2022$698,000
+240.5%
70,470
+237.7%
0.00%
+100.0%
Q1 2022$205,000
-32.3%
20,870
-33.1%
0.00%
-33.3%
Q4 2021$303,000–31,209–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders